By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod made a net profit of CZK 296 mil in 2019, up 77.9% compared to the previous year. Total sales reached...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod made a net profit of CZK 296 mil in 2019, up 77.9% compared to the previous year. Total sales reached...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod employed 774 employees in 2019, down 1.53% compared to the previous year. Historically, betwe...
Profit Statement | 2017 | 2018 | 2019 | |
Sales | CZK mil | 23,446 | 25,006 | 25,613 |
Gross Profit | CZK mil | 743 | 785 | 843 |
EBITDA | CZK mil | 332 | 294 | 341 |
EBIT | CZK mil | 282 | 246 | 290 |
Financing Cost | CZK mil | ... | 110 | 137 |
Pre-Tax Profit | CZK mil | 318 | 195 | 333 |
Net Profit | CZK mil | 273 | 166 | 296 |
Dividends | CZK mil | 221 | 0 | 0 |
Balance Sheet | 2017 | 2018 | 2019 | |
Total Assets | CZK mil | 10,401 | 10,273 | 10,428 |
Non-Current Assets | CZK mil | 2,656 | 2,647 | 3,010 |
Current Assets | CZK mil | 7,740 | 7,622 | 7,411 |
Working Capital | CZK mil | 1,982 | 1,952 | 1,664 |
Shareholders' Equity | CZK mil | 2,228 | 2,395 | 2,691 |
Liabilities | CZK mil | 8,173 | 7,879 | 7,738 |
Total Debt | CZK mil | 1,833 | 1,602 | 1,402 |
Net Debt | CZK mil | ... | -161 | -484 |
Ratios | 2017 | 2018 | 2019 | |
ROE | % | 12.4 | 7.20 | 11.6 |
ROCE | % | 5.81 | 3.60 | 6.39 |
Gross Margin | % | 3.17 | 3.14 | 3.29 |
EBITDA Margin | % | 1.42 | 1.18 | 1.33 |
EBIT Margin | % | 1.20 | 0.984 | 1.13 |
Net Margin | % | 1.16 | 0.665 | 1.16 |
Net Debt/EBITDA | ... | -0.545 | -1.42 | |
Net Debt/Equity | % | ... | -6.71 | -18.0 |
Cost of Financing | % | ... | 6.41 | 9.11 |
Cash Flow | 2017 | 2018 | 2019 | |
Total Cash From Operations | CZK mil | 252 | 78.3 | -72.4 |
Total Cash From Investing | CZK mil | -20.8 | 127 | 315 |
Total Cash From Financing | CZK mil | -224 | -230 | -200 |
Net Change In Cash | CZK mil | 6.90 | -24.4 | 42.3 |
Cash Conversion Cycle | days | 29.2 | 26.9 | 22.0 |
Cash Earnings | CZK mil | 322 | 215 | 347 |
Free Cash Flow | CZK mil | 231 | 206 | 242 |
Get all company financials in excel:
overview | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
income statement | ||||||||||||
Sales | CZK mil | 22,866 | 23,289 | 22,946 | 24,133 | 23,446 | ||||||
Gross Profit | CZK mil | 715 | 725 | 702 | 748 | 743 | ||||||
EBIT | CZK mil | 364 | 351 | 295 | 315 | 282 | ||||||
Net Profit | CZK mil | 220 | 185 | 139 | 259 | 273 | ||||||
ROE | % | ... | 9.70 | 8.13 | 6.37 | 12.0 | 12.4 | |||||
EBIT Margin | % | 1.59 | 1.51 | 1.28 | 1.30 | 1.20 | ||||||
Net Margin | % | 0.961 | 0.793 | 0.607 | 1.07 | 1.16 | ||||||
Employees | 675 | 709 | 715 | 726 | 742 | |||||||
balance sheet | ||||||||||||
Total Assets | CZK mil | 9,525 | 8,884 | 8,990 | 9,733 | 10,401 | ||||||
Non-Current Assets | CZK mil | 2,522 | 2,537 | 2,605 | 2,608 | 2,656 | ||||||
Current Assets | CZK mil | 7,004 | 6,343 | 6,381 | 7,122 | 7,740 | ||||||
Shareholders' Equity | CZK mil | 2,301 | 2,241 | 2,134 | 2,177 | 2,228 | ||||||
Liabilities | CZK mil | 7,224 | 6,642 | 6,856 | 7,556 | 8,173 | ||||||
Non-Current Liabilities | CZK mil | 19.9 | 27.4 | 27.6 | 26.9 | 38.3 | ||||||
Current Liabilities | CZK mil | 7,186 | 6,561 | 6,798 | 7,443 | 8,114 | ||||||
Net Debt/EBITDA | ... | ... | ... | ... | ... | ... | ... | ... | ... | |||
Net Debt/Equity | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
Cost of Financing | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
cash flow | ||||||||||||
Total Cash From Operations | CZK mil | ... | ... | ... | ... | ... | ... | ... | 143 | 252 | ||
Total Cash From Investing | CZK mil | ... | ... | ... | ... | ... | ... | ... | -568 | -20.8 | ||
Total Cash From Financing | CZK mil | ... | ... | ... | ... | ... | ... | ... | 409 | -224 | ||
Net Change In Cash | CZK mil | ... | ... | ... | ... | ... | ... | ... | -15.8 | 6.90 |
income statement | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
income statement | ||||||||||||
Sales | CZK mil | 22,866 | 23,289 | 22,946 | 24,133 | 23,446 | ||||||
Cost of Goods & Services | CZK mil | 22,151 | 22,564 | 22,244 | 23,386 | 22,702 | ||||||
Gross Profit | CZK mil | 715 | 725 | 702 | 748 | 743 | ||||||
Staff Cost | CZK mil | 294 | 321 | 339 | 364 | 396 | ||||||
Other Operating Cost (Income) | CZK mil | 21.4 | 18.4 | 30.2 | 23.9 | 15.4 | ||||||
EBITDA | CZK mil | 400 | 386 | 333 | 360 | 332 | ||||||
Depreciation | CZK mil | 35.5 | 35.0 | 38.4 | 45.1 | 49.7 | ||||||
EBIT | CZK mil | 364 | 351 | 295 | 315 | 282 | ||||||
Net Financing Cost | CZK mil | 89.0 | 117 | 121 | 7.90 | -35.4 | ||||||
Financing Cost | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
Financing Income | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
FX (Gain) Loss | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
Extraordinary Cost | CZK mil | -0.351 | -0.012 | 0 | 0 | 0 | ||||||
Pre-Tax Profit | CZK mil | 275 | 234 | 174 | 307 | 318 | ||||||
Tax | CZK mil | 55.8 | 49.1 | 34.8 | 48.3 | 41.9 | ||||||
Minorities | CZK mil | 0 | 0 | 0 | 0 | 0 | ||||||
Net Profit | CZK mil | 220 | 185 | 139 | 259 | 273 | ||||||
Net Profit Avail. to Common | CZK mil | 220 | 185 | 139 | 259 | 273 | ||||||
Dividends | CZK mil | ... | 148 | 245 | 247 | 216 | 221 | |||||
growth rates | ||||||||||||
Total Revenue Growth | % | ... | -4.46 | 1.85 | -1.47 | 5.17 | -2.85 | |||||
Staff Cost Growth | % | ... | 0.803 | 9.04 | 5.60 | 7.33 | 8.91 | |||||
EBITDA Growth | % | ... | -2.66 | -3.39 | -13.7 | 8.09 | -7.84 | |||||
EBIT Growth | % | ... | 1.34 | -3.59 | -16.0 | 6.85 | -10.4 | |||||
Pre-Tax Profit Growth | % | ... | -0.376 | -15.1 | -25.5 | 76.3 | 3.44 | |||||
Net Profit Growth | % | ... | 1.89 | -15.9 | -24.5 | 85.6 | 5.39 | |||||
ratios | ||||||||||||
ROE | % | ... | 9.70 | 8.13 | 6.37 | 12.0 | 12.4 | |||||
ROA | % | ... | 2.44 | 2.01 | 1.56 | 2.76 | 2.71 | |||||
ROCE | % | ... | 8.12 | 6.27 | 4.30 | 6.35 | 5.81 | |||||
Gross Margin | % | 3.13 | 3.11 | 3.06 | 3.10 | 3.17 | ||||||
EBITDA Margin | % | 1.75 | 1.66 | 1.45 | 1.49 | 1.42 | ||||||
EBIT Margin | % | 1.59 | 1.51 | 1.28 | 1.30 | 1.20 | ||||||
Net Margin | % | 0.961 | 0.793 | 0.607 | 1.07 | 1.16 | ||||||
Payout Ratio | % | ... | 67.2 | 132 | 177 | 83.5 | 81.1 | |||||
Cost of Financing | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
Net Debt/EBITDA | ... | ... | ... | ... | ... | ... | ... | ... | ... |
balance sheet | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
balance sheet | ||||||||||||
Cash & Cash Equivalents | CZK mil | 73.3 | 65.1 | 87.6 | 71.8 | 78.7 | ||||||
Receivables | CZK mil | 3,575 | 3,705 | 3,738 | 5,027 | 5,312 | ||||||
Inventories | CZK mil | 2,080 | 1,973 | 2,096 | 2,023 | 2,349 | ||||||
Current Assets | CZK mil | 7,004 | 6,343 | 6,381 | 7,122 | 7,740 | ||||||
Property, Plant & Equipment | CZK mil | 810 | 825 | 894 | 894 | 942 | ||||||
LT Investments & Receivables | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
Intangible Assets | CZK mil | 1.66 | 2.28 | 2.70 | 4.44 | 4.75 | ||||||
Goodwill | CZK mil | 0 | 0 | 0 | 0 | 0 | ||||||
Non-Current Assets | CZK mil | 2,522 | 2,537 | 2,605 | 2,608 | 2,656 | ||||||
Total Assets | CZK mil | 9,525 | 8,884 | 8,990 | 9,733 | 10,401 | ||||||
Trade Payables | CZK mil | 5,356 | 5,144 | 5,034 | 4,915 | 5,679 | ||||||
Short-Term Debt | CZK mil | 1,207 | 922 | 1,200 | 1,834 | 1,833 | ||||||
Other ST Liabilities | CZK mil | 622 | 496 | 564 | 694 | 602 | ||||||
Current Liabilities | CZK mil | 7,186 | 6,561 | 6,798 | 7,443 | 8,114 | ||||||
Long-Term Debt | CZK mil | 4.07 | 6.19 | 0 | 0 | 0 | ||||||
Other LT Liabilities | CZK mil | 15.8 | 21.2 | 27.6 | 26.9 | 38.3 | ||||||
Non-Current Liabilities | CZK mil | 19.9 | 27.4 | 27.6 | 26.9 | 38.3 | ||||||
Liabilities | CZK mil | 7,224 | 6,642 | 6,856 | 7,556 | 8,173 | ||||||
Equity Before Minority Interest | CZK mil | 2,301 | 2,241 | 2,134 | 2,177 | 2,228 | ||||||
Minority Interest | CZK mil | 0 | 0 | 0 | 0 | 0 | ||||||
Equity | CZK mil | 2,301 | 2,241 | 2,134 | 2,177 | 2,228 | ||||||
growth rates | ||||||||||||
Total Asset Growth | % | ... | 12.0 | -6.74 | 1.19 | 8.27 | 6.87 | |||||
Shareholders' Equity Growth | % | ... | 3.23 | -2.60 | -4.79 | 2.00 | 2.37 | |||||
Net Debt Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
Total Debt Growth | % | ... | 70.7 | -23.4 | 29.4 | 52.8 | -0.048 | |||||
ratios | ||||||||||||
Total Debt | CZK mil | 1,211 | 928 | 1,200 | 1,834 | 1,833 | ||||||
Net Debt | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
Working Capital | CZK mil | 299 | 534 | 800 | 2,135 | 1,982 | ||||||
Capital Employed | CZK mil | 2,821 | 3,070 | 3,406 | 4,743 | 4,638 | ||||||
Net Debt/Equity | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
Current Ratio | 0.975 | 0.967 | 0.939 | 0.957 | 0.954 | |||||||
Quick Ratio | 0.508 | 0.575 | 0.563 | 0.685 | 0.664 |
cash flow | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
cash flow | ||||||||||||
Net Profit | CZK mil | 220 | 185 | 139 | 259 | 273 | ||||||
Depreciation | CZK mil | 35.5 | 35.0 | 38.4 | 45.1 | 49.7 | ||||||
Non-Cash Items | CZK mil | ... | ... | ... | ... | ... | ... | ... | 1,173 | -224 | ||
Change in Working Capital | CZK mil | ... | -212 | -235 | -267 | -1,335 | 153 | |||||
Total Cash From Operations | CZK mil | ... | ... | ... | ... | ... | ... | ... | 143 | 252 | ||
Capital Expenditures | CZK mil | ... | ... | ... | ... | ... | ... | ... | -57.8 | -74.9 | ||
Other Investing Activities | CZK mil | ... | ... | ... | ... | ... | ... | ... | -510 | 54.1 | ||
Total Cash From Investing | CZK mil | ... | ... | ... | ... | ... | ... | ... | -568 | -20.8 | ||
Dividends Paid | CZK mil | ... | -148 | -245 | -247 | -216 | -221 | |||||
Issuance Of Debt | CZK mil | ... | 502 | -284 | 272 | 634 | -0.880 | |||||
Total Cash From Financing | CZK mil | ... | ... | ... | ... | ... | ... | ... | 409 | -224 | ||
Net Change In Cash | CZK mil | ... | ... | ... | ... | ... | ... | ... | -15.8 | 6.90 | ||
ratios | ||||||||||||
Days Sales Outstanding | days | 57.1 | 58.1 | 59.5 | 76.0 | 82.7 | ||||||
Days Sales Of Inventory | days | 34.3 | 31.9 | 34.4 | 31.6 | 37.8 | ||||||
Days Payable Outstanding | days | 88.3 | 83.2 | 82.6 | 76.7 | 91.3 | ||||||
Cash Conversion Cycle | days | 3.08 | 6.77 | 11.3 | 30.9 | 29.2 | ||||||
Cash Earnings | CZK mil | 255 | 220 | 178 | 304 | 322 | ||||||
Free Cash Flow | CZK mil | ... | ... | ... | ... | ... | ... | ... | -425 | 231 | ||
Capital Expenditures (As % of Sales) | % | ... | ... | ... | ... | ... | ... | ... | 0.239 | 0.320 |
other ratios | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
Employees | 675 | 709 | 715 | 726 | 742 | |||||||
Cost Per Employee | USD per month | 1,856 | 1,764 | 1,654 | 1,654 | 1,895 | ||||||
Cost Per Employee (Local Currency) | CZK per month | 36,320 | 37,703 | 39,479 | 41,731 | 44,470 | ||||||
Staff Cost (As % of Sales) | % | 1.29 | 1.38 | 1.48 | 1.51 | 1.69 | ||||||
Effective Tax Rate | % | 20.2 | 21.0 | 20.0 | 15.7 | 13.2 | ||||||
Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | -3.90 | -2.16 | -0.704 | -0.412 | ||
Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Get all company financials in excel:
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod employed 774 employees in 2019, down 1.53% compared to the previous year. Historically, between 2009 and 2019, the firm's workforce hit a high of 786 employees in 2018 and a low of 666 employees in 2011. Average personn...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod made a net profit of CZK 296 mil with revenues of CZK 25,613 mil in 2019, up by 77.9% and up by 2.42%, respectively, compared to the previous year. This translates into a net margin of 1.16%. Historically, between 2009 and...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod made a net profit of CZK 296 mil with revenues of CZK 25,613 mil in 2019, up by 77.9% and up by 2.42%, respectively, compared to the previous year. This translates into a net margin of 1.16%. Historically, between 2009 and...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod's total assets reached CZK 10,428 mil at the end of 2019, up 1.51% compared to the previous year. Current assets amounted to CZK 7,411 mil, or 71.1% of total assets while cash stood at CZK 96.5 mil at the end ...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod's total assets reached CZK 10,428 mil at the end of 2019, up 1.51% compared to the previous year. Current assets amounted to CZK 7,411 mil, or 71.1% of total assets while cash stood at CZK 96.5 mil at the end ...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod made a net profit of CZK 296 mil in 2019, up 77.9% compared to the previous year. Historically, between 2009 and 2019, the company's net profit reached a high of CZK 296 mil in 2019 and a low of CZK 139 mil in 2015. The resu...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod made a net profit of CZK 296 mil in 2019, up 77.9% compared to the previous year. Historically, between 2009 and 2019, the company's net profit reached a high of CZK 296 mil in 2019 and a low of CZK 139 mil in 2015. The resu...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod's net debt stood at CZK -484 mil and accounted for -18.0% of equity at the end of 2019. The ratio is down 11.3 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of -6.71% in 20...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod's net debt stood at CZK -484 mil and accounted for -18.0% of equity at the end of 2019. The ratio is down 11.3 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of -6.71% in 20...
Phoenix Lekárenský Velkoobchod, a.s. is a Czech Republic-based pharmaceutical distributor. With a market share of nearly 40%, the Company is clearly the leader on the Czech wholesale pharmaceutical market. The Company operates six warehouses throughout the Czech Republic (Praha, Brno, Ostrava, Plzeň, Vysoké Mýto, Ševětín). The Company supplies pharmacies and hospitals with pharmaceutical products, offers warehouse services to pharmaceutical producers and runs a network of its own pharmacies through its subsidiary BENU Česká republika. Phoenix Lekarensky Velkoobchod operates as a subsidiary of PHOENIX Pharmahandel Aktiengesellschaft & Co. KG.
PHOENIX Lekarensky Velkoobchod has been growing its sales by 1.92% a year on average in the last 5 years. EBITDA has fallen on average by 2.47% a year during that time to total of CZK 341 mil in 2019, or 1.33% of sales. That’s compared to 1.37% average margin seen in last five years.
The company netted CZK 296 mil in 2019 implying ROE of 11.6% and ROCE of 6.39%. Again, the average figures were 9.92% and 5.29%, respectively when looking at the previous 5 years.
PHOENIX Lekarensky Velkoobchod’s net debt amounted to CZK -484 mil at the end of 2019, or -18.0% of equity. When compared to EBITDA, net debt was -1.42x, down when compared to average of -0.983x seen in the last 5 years.